Regime of Use of Rituximab in Patients with Rheumatoid Arthritis in Daily Clinical Practice.

被引：0
|
作者：
Merino-Melendez, Leticia [1 ]
Llorente, Irene [1 ]
Castaneda, Santos [2 ]
Velasco, Teresa [1 ]
Sala-Icardo, Luis [3 ]
Garcia-Vicuna, Rosario [3 ]
Garcia-Vadillo, Alberto [1 ]
Lopez-Bote, Juan P. [3 ]
Lopez-Lopez, Jorge [1 ]
Herrera, Federico [1 ]
Munoz-Calleja, Cecilia [1 ]
Alvaro-Gracia, J. M. [1 ]
Gonzalez-Alvaro, Isidoro [3 ]
机构：
[1] Hosp Univ La Princesa, Madrid, Spain
[2] Hosp Univ La Princesa, IISP, Madrid, Spain
[3] Hosp Univ La Princesa, IIS La Princesa, Madrid, Spain
来源：
ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2412
引用
收藏
页码：S1051 / S1052
页数：2
相关论文
共 50 条
  • [41] The three-year efficacy of iguratimod in clinical daily practice in patients with rheumatoid arthritis
    Suto, Takahito
    Yonemoto, Yukio
    Okamura, Koichi
    Sakane, Hideo
    Takeuchi, Kimihiko
    Tamura, Yasuyuki
    Kaneko, Tetsuya
    Ayabe, Keio
    Chikuda, Hirotaka
    MODERN RHEUMATOLOGY, 2019, 29 (05) : 775 - 781
  • [42] Dose reduction of rituximab in clinical practice: a retrospective cohort study of rheumatoid arthritis patients in low disease activity on rituximab
    Wientjes, M. H. M.
    van Huissteden, J.
    van Herwaarden, N.
    Verhoef, L. M.
    den Broeder, A. A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (11) : 2215 - 2220
  • [43] Could we use a lower dose of rituximab to treat rheumatoid arthritis in clinical practice: pros and cons?
    Gianfranco Ferraccioli
    Barbara Tolusso
    Elisa Gremese
    Arthritis Research & Therapy, 18
  • [44] Could we use a lower dose of rituximab to treat rheumatoid arthritis in clinical practice: pros and cons?
    Ferraccioli, Gianfranco
    Tolusso, Barbara
    Gremese, Elisa
    ARTHRITIS RESEARCH & THERAPY, 2016, 18
  • [45] Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
    Buch, Maya H.
    Smolen, Josef S.
    Betteridge, Neil
    Breedveld, Ferdinand C.
    Burmester, Gerd
    Doerner, Thomas
    Ferraccioli, Gianfranco
    Gottenberg, Jacques-Eric
    Isaacs, John
    Kvien, Tore K.
    Mariette, Xavier
    Martin-Mola, Emilio
    Pavelka, Karel
    Tak, Paul P.
    van der Heijde, Desiree
    van Vollenhoven, Ronald F.
    Emery, Paul
    ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (06) : 909 - 920
  • [46] Safety of infliximab in daily practice in patients with rheumatoid arthritis.
    Neven, N
    Vis, M
    Voskuyl, AE
    Wolbink, GJ
    Nurmohamed, MT
    Dijkmans, BAC
    Lems, WF
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S331 - S331
  • [47] Difficult-to-treat rheumatoid arthritis in real clinical practice. Preliminary results
    Galushko, Elena A.
    Gordeev, Andrey V.
    Matyanova, Elena V.
    Olyunin, Yury A.
    Nasonov, Evgeny L.
    TERAPEVTICHESKII ARKHIV, 2022, 94 (05) : 661 - 666
  • [48] Effectiveness and safety of etanercept for the treatment of juvenile rheumatoid arthritis (JRA) in clinical practice.
    Brunner, HI
    Tomasi, AL
    Sherrard, TM
    Taylor, J
    Passo, MH
    Graham, TB
    Lovell, DJ
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S292 - S292
  • [49] Infliximab and non-methotrexate DMARDS for rheumatoid arthritis: Efficacy in clinical practice.
    Watson, K
    Hyrich, K
    Lunt, M
    Silman, A
    Symmons, D
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S190 - S190
  • [50] Efficacy and safety at 24 weeks of daily clinical use of tofacitinib in patients with rheumatoid arthritis
    Iwamoto, Naoki
    Tsuji, Sosuke
    Takatani, Ayuko
    Shimizu, Toshimasa
    Fukui, Shoichi
    Umeda, Masataka
    Nishino, Ayako
    Horai, Yoshiro
    Koga, Tomohiro
    Kawashiri, Shin-ya
    Aramaki, Toshiyuki
    Ichinose, Kunihiro
    Hirai, Yasuko
    Tamai, Mami
    Nakamura, Hideki
    Terada, Kaoru
    Origuchi, Tomoki
    Eguchi, Katsumi
    Ueki, Yukitaka
    Kawakami, Atsushi
    PLOS ONE, 2017, 12 (05):
12345